Triglyceride-Glucose-Waist-to-Weight Index: Novel Biomarker for Mild Cognitive Impairment in Older People With Sarcopenic Obesity - PubMed
2 hours ago
- #Cognitive Impairment
- #Sarcopenic Obesity
- #Biomarker
- Sarcopenic obesity (SO) is strongly linked to mild cognitive impairment (MCI) in older adults.
- Traditional SO criteria overlook insulin resistance, a key factor in MCI development.
- The study uses data from three cohorts: Chongming Screening Project (2025), CHARLS, and ELSA.
- A metabolically oriented SO definition combining sarcopenia with elevated TyG-WWI index shows consistent association with MCI across all cohorts.
- TyG-WWI is identified as the optimal obesity indicator for MCI detection, with an AUC of 0.71.
- An XGBoost model incorporating TyG-WWI achieves high discriminative performance for MCI risk in both cross-sectional and external validation studies.
- Subgroup analyses indicate SO is particularly associated with declines in executive function and memory.
- The findings suggest that metabolic-focused SO criteria are more effective than traditional body composition-based ones for identifying MCI in older community-dwelling individuals.